Mark Stroh
Impact in
-
- Regulation of Appetite and Obesity
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- PARP inhibition in cancer therapy 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Geoffrey M. Kuziemko (2 shared papers)Raymond C. Stevens (2 shared papers)John P. Zimmer (2 shared papers)Moungi G. Bawendi (2 shared papers)Dan Gabriel Duda (2 shared papers)Yinthai Chan (1 shared paper)Jonathan S. Steckel (1 shared paper)David T. Scadden (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (6 papers)Clinical Pharmacology & Therapeutics (6 papers)American Journal of Therapeutics (4 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)The AAPS Journal (3 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Mark Stroh
47 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 69
- Endocrine and Autonomic Systems 59
- Oncology 162
- Materials Chemistry 260
- Endocrinology 24
- Organic Chemistry 140
Countries citing papers authored by Mark Stroh
This map shows the geographic impact of Mark Stroh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stroh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stroh more than expected).
Fields of papers citing papers by Mark Stroh
This network shows the impact of papers produced by Mark Stroh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stroh. The network helps show where Mark Stroh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stroh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 366 | |
| 2 | 1996 | 286 | |
| 3 | 1996 | 215 | |
| 4 | 2004 | 201 | |
| 5 | 2016 | 135 | |
| 6 | 2007 | 131 | |
| 7 | 2003 | 63 | |
| 8 | 2018 | 60 | |
| 9 | 2009 | 58 | |
| 10 | 2021 | 54 | |
| 11 | 2016 | 45 | |
| 12 | 2011 | 43 | |
| 13 | 2018 | 33 | |
| 14 | 2021 | 33 | |
| 15 | 2004 | 30 | |
| 16 | 2004 | 26 | |
| 17 | 2017 | 23 | |
| 18 | 2021 | 23 | |
| 19 | 2013 | 18 | |
| 20 | 2014 | 16 |
About Mark Stroh
Mark Stroh is a scholar working on Pharmacology, Oncology, Statistics and Probability, Molecular Biology and Endocrinology, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Pharmacogenetics and Drug Metabolism (8 papers), Quantum Dots Synthesis And Properties (3 papers), Lung Cancer Treatments and Mutations (2 papers), Statistical Methods in Clinical Trials (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), PARP inhibition in cancer therapy (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (59 citations), Oncology (162 citations), Materials Chemistry (260 citations), Endocrinology (24 citations) and Organic Chemistry (140 citations). Mark Stroh has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Geoffrey M. Kuziemko, Raymond C. Stevens, John P. Zimmer, Moungi G. Bawendi, Dan Gabriel Duda, Yinthai Chan, Jonathan S. Steckel, David T. Scadden, Dai Fukumura and Edward B. Brown. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Clinical Pharmacology & Therapeutics, American Journal of Therapeutics, CPT Pharmacometrics & Systems Pharmacology and The AAPS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.